EFSA health claim opinion
Prebiotic inulin wins EFSA bowel health claim
“Six studies involving 86 subjects consistently showed that consumption of ‘native chicory inulin’ at an amount of at least 12 g/day increases stool frequency,” wrote EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) in the article 13.5 proprietary science opinion under the EU nutrition and health claim regulation (NHCR).
Article 13.5 protects proprietary science for five years.
It therefore backed the claim: “Chicory inulin contributes to maintenance of normal defecation by increasing stool frequency.”
Of the approval, Beneo VP of regulatory affairs and nutrition communication Anke Sentko noted, “The positive evaluation by EFSA shows once again that Beneo is on the right track to further invest in research and focus on sound scientific substantiation of its products’ benefits. Digestive health, including regularity, is an important element of feeling good, especially due to the fact we often have a ‘lazy’ gut.”
“Improved regularity in a natural way is a growing health target of consumers.”
The NDA opinion is here.
It follows an approval won by Beneo (Germany and Belgium), Sensus (the Netherlands) and Cosucra-Groupe Warcoing (Belgium) 12 months ago linking non-digestible carbohydrates including inulin with lower blood glucose rise after meals compared to sugar-containing foods/drinks.
Pre- and probiotics will be discussed at Probiota 2015 in Amsterdam on February 3-5 – less than a month away.
From the next wave of prebiotics to the future of microbiome science beyond probiotics and prebiotics, to the nutrients’ effect on mood and anxiety, and strategies on pre- and probiotic market building, Probiota 2015 is a knowledge store you probably shouldn’t miss.
Click here for more.
